Biocartis Group, 4.5% 9may2024, EUR (Conv.) (FIGI BBG01B87NMN1, BE6338582206, WKN A3LA0M)
国内債券, 転換社債, Secured
国内債券, 転換社債, Secured
|
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry, with a focus on oncology.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
100 000
株
175 910
ETF&投資信託
100 000
インデックス
最も効率的な方法でポートフォリオを追跡